Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398080
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-04-17
Brief Title:
An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration nAMD and Diabetic Macular Edema DME in a Real-World Setting
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-11-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-13
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-17
First Submit QC Date:
April 30 2024
Study First Post Date:
2024-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-30
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL